140 related articles for article (PubMed ID: 7873470)
1. Regression of left ventricular hypertrophy and improvement of renal hemodynamics in hypertensive patients treated with quinapril.
De Caprio L; De Rosa ML; Di Palma A; Lirato C; Caccese P; Sestito M; Lastoria S; Cicatiello AM; Rengo F
Cardiovasc Drugs Ther; 1994 Oct; 8(5):735-40. PubMed ID: 7873470
[TBL] [Abstract][Full Text] [Related]
2. Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation.
Suwelack B; Gerhardt U; Hausberg M; Rahn KH; Hohage H
Am J Cardiol; 2000 Sep; 86(5):583-5, A10. PubMed ID: 11009288
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of quinapril on regional blood flow and cardiac function in patients with congestive heart failure.
Munger MA; Chance M; Nair R; Prescott AW; Nara AR; Simonson MS; Green JA; Posvar EL
J Clin Pharmacol; 1992 Jan; 32(1):70-6. PubMed ID: 1740540
[TBL] [Abstract][Full Text] [Related]
4. Vascular structure in the forearm and calf after 6 months of angiotensin converting enzyme inhibition in elderly hypertensive subjects with left ventricular hypertrophy.
Marceau M; Kouamé N; Lacourcière Y; Cléroux J
J Hypertens; 1998 May; 16(5):673-9. PubMed ID: 9797179
[TBL] [Abstract][Full Text] [Related]
5. Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study.
Miller MA; Texter M; Gmerek A; Robbins J; Shurzinske L; Canter D
Cardiovasc Drugs Ther; 1994 Apr; 8(2):271-5. PubMed ID: 7918140
[TBL] [Abstract][Full Text] [Related]
6. Effects of quinapril hydrochloride in patients with essential hypertension and impaired renal function.
Owada A; Nonoguchi H; Terada Y; Marumo F; Tomita K
Clin Exp Hypertens; 1997 May; 19(4):495-502. PubMed ID: 9140710
[TBL] [Abstract][Full Text] [Related]
7. [Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models].
Yaoka O; Aoki K; Nakajima T; Setoguchi M
Nihon Yakurigaku Zasshi; 1993 Jul; 102(1):35-45. PubMed ID: 8335286
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor.
Gupta RK; Kjeldsen SE; Krause L; Kneisley J; Posvar E; Weder AB; Julius S
Clin Pharmacol Ther; 1990 Jul; 48(1):41-9. PubMed ID: 2196144
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effects of quinapril after myocardial infarction in hypertensive rats.
Mori T; Nishimura H; Okabe M; Ueyama M; Kubota J; Kawamura K
Eur J Pharmacol; 1998 May; 348(2-3):229-34. PubMed ID: 9652338
[TBL] [Abstract][Full Text] [Related]
10. Comparative effect of clinidipine and quinapril on left ventricular mass in mild essential hypertension.
Sakata K; Yoshida H; Tamekiyo H; Obayashi K; Nawada R; Doi O; Mori N
Drugs Exp Clin Res; 2003; 29(3):117-23. PubMed ID: 14708457
[TBL] [Abstract][Full Text] [Related]
11. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension.
Sánchez S; Luna A; Orozco R; Velasco G
Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of three trials with quinapril in the treatment of mild-to-moderate hypertension in the Mexican population.
Alcocer L; Novoa G; Sotres D
Clin Ther; 1995; 17(3):552-60; discussion 516. PubMed ID: 7585859
[TBL] [Abstract][Full Text] [Related]
13. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
Lacourcière Y; Lefebvre J; Provencher P; Poirier L
Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029
[TBL] [Abstract][Full Text] [Related]
14. How should we treat hypertensive women with cardiac and renal impairment?
Ruilope LM; Suarez C
Am J Hypertens; 1997 Oct; 10(10 Pt 2):242S-246S. PubMed ID: 9366280
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of action of quinapril in the treatment of primary arterial hypertension].
Gambini G; Pinchi G; Valori C
Recenti Prog Med; 1999 Dec; 90(12):654-7. PubMed ID: 10676106
[TBL] [Abstract][Full Text] [Related]
16. Effect of quinapril and triamterene/hydrochlorothiazide on cardiac and vascular end-organ damage in isolated systolic hypertension.
Heesen WF; Beltman FW; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Meyboom-de Jong B; Lie KI
J Cardiovasc Pharmacol; 1998 Feb; 31(2):187-94. PubMed ID: 9475259
[TBL] [Abstract][Full Text] [Related]
17. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
Romero R; Castellote E; Ocón J; Wagner B
J Cardiovasc Pharmacol; 1995 Jul; 26(1):114-8. PubMed ID: 7564350
[TBL] [Abstract][Full Text] [Related]
18. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
Teisman AC; Pinto YM; Buikema H; Flesch M; Böhm M; Paul M; van Gilst WH
J Hypertens; 1998 Dec; 16(12 Pt 1):1759-65. PubMed ID: 9869009
[TBL] [Abstract][Full Text] [Related]
20. [A comparative study of the efficacy of lisinopril versus quinapril in controlling light to moderate arterial hypertension. A follow-up with ABPM].
Motero Carrasco J
Rev Esp Cardiol; 1995 Nov; 48(11):746-53. PubMed ID: 8532944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
